No Data Available
Windlas Biotech Share Price
| Open | 821.90 |
| High | 821.90 |
| Low | 804.00 |
| Prev Close | 819.75 |
| Volume | 47,368 |
| VWAP(₹) | 810.44 |
Key Metrics
| PE Ratio(x) | 25.19 |
| EPS - TTM(₹) | 32.20 |
| MCap(₹ Cr.) | 1,674.22 |
| MCap Rank | 93 |
| PB Ratio(x) | 2.91 |
| Div Yield(%) | - |
| Face Value(₹) | 5.00 |
| 52W High(₹) | 1,097.90 |
| 52W Low(₹) | 697.40 |
| MCap/Sales | 1.72 |
| Beta(1 Month) | - |
| BV/Share(₹) | 281.47 |
Windlas Biotech share price insights
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 16.82% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Windlas Biotech Share Price Update
Windlas Biotech Ltd. share price moved down by -1.04% from its previous close of Rs 819.75. Windlas Biotech Ltd. stock last traded price is 811.30
Share Price Value Today/Current/Last 811.30 Previous Day 819.75
Found Insights useful?
Windlas Biotech Share Price Returns
| 1 Day | -1.04% |
| 1 Month | 1.56% |
| 3 Months | 9.29% |
| 1 Year | -12.2% |
| 3 Years | 192.84% |
| 5 Years | N.A. |
Windlas Biotech Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
News
Windlas Biotech announces Rs 47 crore buyback at Rs 1,000/share; sets April 24 as record date
News
Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out forAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
AnnouncementsCompliances-Reg.24(A)-Annual Secretarial Compliance
Announcements
Financials
Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Total Income 242.85 237.67 226.04 215.33 207.64 Total Income Growth (%) 2.18 5.14 4.98 3.70 4.28 Total Expenses 221.21 216.42 201.44 191.01 185.49 Total Expenses Growth (%) 2.21 7.44 5.46 2.98 4.60 EBIT 21.64 21.25 24.60 24.32 22.15 EBIT Growth (%) 1.83 -13.64 1.19 9.77 1.61 Profit after Tax (PAT) 15.99 15.00 17.80 17.66 16.28 PAT Growth (%) 6.59 -15.72 0.77 8.49 4.53 EBIT Margin (%) 8.91 8.94 10.88 11.29 10.67 Net Profit Margin (%) 6.58 6.31 7.87 8.20 7.84 Basic EPS (₹) 7.58 7.12 8.48 8.43 7.77 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 16.82% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Assets 907.35 760.45 626.21 528.98 491.01 Total Assets Growth (%) 19.32 21.44 18.38 7.73 65.81 Total Liabilities 326.51 254.68 176.27 126.70 96.23 Total Liabilities Growth (%) 28.21 44.48 39.12 31.66 -0.79 Total Equity 580.84 505.77 449.94 402.27 394.78 Total Equity Growth (%) 14.84 12.41 11.85 1.90 98.26 Current Ratio (x) 1.95 2.11 2.51 2.92 4.02 Total Debt to Equity (x) 0.05 0.05 0.00 0.00 0.02 Contingent Liabilities 0.00 2.08 15.29 14.11 3.25 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities 104.93 68.19 108.96 60.97 9.13 Net Cash used in Investing Activities -91.79 -74.06 -92.07 -14.11 -154.58 Net Cash flow from Financing Activities -13.03 1.01 -15.29 -43.74 130.09 Net Cash Flow 0.11 -4.86 1.60 3.12 -15.36 Closing Cash & Cash Equivalent 0.54 0.42 5.29 3.69 0.57 Closing Cash & Cash Equivalent Growth (%) 26.18 -91.98 43.46 546.67 -96.42 Total Debt/ CFO (x) 0.28 0.40 0.00 0.01 0.67 All figures in Rs Cr, unless mentioned otherwise
InsightsIncrease in Cash from Investing
Company has used Rs 91.79 cr for investing activities which is an YoY increase of 23.93%. (Source: Consolidated Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Return on Equity (%) 11.44 11.95 12.87 10.59 9.64 Return on Capital Employed (%) 15.65 16.46 17.20 14.18 11.83 Return on Assets (%) 7.32 7.94 9.25 8.05 7.75 Interest Coverage Ratio (x) 25.39 25.59 82.93 89.07 41.73 Asset Turnover Ratio (x) 1.08 1.10 1.09 1.01 1.18 Price to Earnings (x) 23.47 36.23 18.42 11.06 12.03 Price to Book (x) 2.68 4.31 2.37 1.17 1.16 EV/EBITDA (x) 12.93 19.56 11.29 6.36 5.92 EBITDA Margin (%) 13.55 14.75 14.52 13.68 12.69
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
Mutual Funds Ownership
MF Ownership as on 30 April 2026
73.06
Amount Invested (in Cr.)
1.09550921%
% of AUM
0.00
% Change (MoM basis)
20.65
Amount Invested (in Cr.)
0.08%
% of AUM
3.86
% Change (MoM basis)
17.04
Amount Invested (in Cr.)
0.19490239%
% of AUM
-15.80
% Change (MoM basis)
Windlas Biotech Top Searches
Corporate Actions
Final
126%
May 21, 2026
Board Meeting
Audited Results & Final Dividend
May 15, 2026
General Meeting
Buy Back of Shares.
Apr 17, 2026
Announced on Meeting on May 15, 2026 May 21, 2026 Audited Results & Final Dividend Apr 15, 2026 Apr 17, 2026 Buy Back of Shares Jan 28, 2026 Feb 05, 2026 Quarterly Results Oct 29, 2025 Nov 06, 2025 Quarterly Results Aug 06, 2025 Aug 12, 2025 Quarterly Results Announced on Ex-Date Dividend% May 22, 2025 Jul 21, 2025 116% May 21, 2024 Sep 17, 2024 110% May 05, 2023 Sep 05, 2023 80% May 12, 2022 Sep 09, 2022 70% May 21, 2026 - 126% No Data Available
No Data Available
No Data Available
Announced on Meeting on Apr 17, 2026 - Buy Back of Shares. Apr 17, 2026 - Buy Back of Shares. Apr 17, 2026 - Buy Back of Shares. Apr 17, 2026 - Buy Back of Shares. Apr 17, 2026 - Buy Back of Shares.
About Windlas Biotech
Industry
Key Indices Listed On
BSE SmallCap, BSE Healthcare, BSE AllCap, BSE MidSmallCap
Address
40/1, Mohabewala Industrial Area,Dehradun, Uttarakhand/Uttaranchal - 248110
Executive Leadership
Vivek Dhariwal
Chairman & Ind.DirectorHitesh Windlass
Managing DirectorManoj Kumar Windlass
Joint Managing DirectorKomal Gupta
CEO & CFOAuditors
FAQs about Windlas Biotech share
- 1. What's the Windlas Biotech share price today?As on 11 Jun, 2026, 03:40 PM IST Windlas Biotech share price is down by 1.04% basis the previous closing price of Rs 835.4. Windlas Biotech share price is Rs 811.30. Return Performance of Windlas Biotech Shares:
- 1 Week: Windlas Biotech share price moved up by 0.02%
- 2. What is the market cap of Windlas Biotech?Windlas Biotech share has a market capitalization of Rs 1,674.22 Cr. Within General sector, it's market cap rank is 93.
- 3. What are the returns for Windlas Biotech share?Return Performance of Windlas Biotech Shares:
- 1 Week: Windlas Biotech share price moved up by 0.02%
- 4. What is the PE & PB ratio of Windlas Biotech?The PE ratio of Windlas Biotech stands at 25.46, while the PB ratio is 2.98.
- 5. What is Windlas Biotech's 52 week high / low?In last 52 weeks Windlas Biotech share had a high price of Rs 1,097.90 and low price of Rs 697.40
Top Gainers
As on 03:59 PM | 11 Jun 2026Top Losers
As on 03:59 PM | 11 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.